Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Details Textual)

v3.10.0.1
Description of Business and Summary of Significant Accounting Policies (Details Textual) - USD ($)
1 Months Ended 6 Months Ended
Aug. 31, 2018
Jun. 30, 2018
Dec. 31, 2017
Description of Business and Summary of Significant Accounting Policies (Textual)      
Description of patient enrollment   The SIERRA trial reached 25% patient enrollment in June 2018.  
Deposit amount   $ 390,940 $ 390,940
Restricted cash   $ 40,034
Subsequent event [Member]      
Description of Business and Summary of Significant Accounting Policies (Textual)      
Description of patent portfolio

The Company’s patent portfolio includes: 74 issued and pending patent applications, of which 11 are issued in the United States, 10 are pending in the United States, and 55 are issued internationally and pending internationally.

   
Furniture and fixtures [Member]      
Description of Business and Summary of Significant Accounting Policies (Textual)      
Estimated useful lives   Three years  
Property and equipment depreciation method   Straight-line basis  
Machinery and equipment [Member]      
Description of Business and Summary of Significant Accounting Policies (Textual)      
Estimated useful lives   Three years  
Property and equipment depreciation method   Straight-line basis